We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Surveillance Trial Offers Peace of Mind for High-risk BRCA-carriers

News   Aug 23, 2018 | Original story sourced from University College Hospitals London

 
Avoiding Late Diagnosis of Ovarian Cancer

The ALDO (Avoiding Late Diagnosis of Ovarian Cancer) project is a partnership between UCLH Cancer Collaborative and Abcodia Ltd. The project was conceived as part of the Cancer Vanguard’s challenge to industry in 2017, to work with the NHS on projects to improve the early diagnosis of cancer. Photo credit: Pixabay

 
 
 

RELATED ARTICLES

Membrane Proteins Ejected Directly from Cell Membrane to Mass Spec

News

A new approach to analyzing cell membrane proteins in situ could revolutionize the way in which we study diseases, such as cancer, metabolic and heart diseases.

READ MORE

Determining the Likelihood of Long-term Brain Damage in Newborns

News

A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

READ MORE

Researchers Identify Mechanism That Fuels Cancer Cells’ Growth

News

Scientists have identified sodium glucose transporter 2 (SGLT2) as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE